Form 8.3 - Horizon Therapeutics plc

LONDON--(BUSINESS WIRE)-- 

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Millennium International Management LP
Company dealt in	Horizon Therapeutics plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	IE00BQPVQZ61
Date of dealing	4^th April 2023

2. INTERESTS AND SHORT POSITIONS

1. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	4,252,383 (1.859%)		23,466 (0.010%)
(2) Derivatives (other than options)	-		-
(3) Options and agreements to purchase/sell	205,500 (0.090%)		828,900 (0.362%)
Total	4,457,883 (1.949%)		852,366 (0.373%)

b. Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

3. DEALINGS (Note 4)

1. Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit (USD) (Note 5)
108.88	53	108.88
108.85	131	108.85
108.35	392	108.35
108.42	100	108.42
108.33	1,153	108.33
108.36	500	108.36
108.37	100	108.37
108.30	255	108.30
108.84	50	108.84
108.80	550	108.80
108.85	200	108.85
108.82	50	108.82
108.66	100	108.66
108.79	134	108.79
108.48	2	108.48
108.74	100	108.74
108.54	5,739	108.54
108.85	458	108.85
108.77	916	108.77
108.86	372	108.86
108.78	204	108.78
108.35	612	108.35
108.92	181	108.92
108.82	201	108.82
108.53	360	108.53
108.76	271	108.76
108.52	919	108.52
108.57	53	108.57
108.42	154	108.42
108.33	671	108.33
108.45	67	108.45
108.46	72	108.46
108.83	497	108.83
108.29	139	108.29
108.43	11	108.43
108.35	26	108.35
108.54	41	108.54
108.80	38	108.80
108.85	21	108.85
108.60	14	108.60
108.35	40	108.35
108.82	11	108.82
108.76	47	108.76
108.57	27	108.57
108.42	40	108.42
108.79	10	108.79
108.87	14	108.87
108.71	102	108.71
108.36	41	108.36
108.43	21	108.43
108.54	9,758	108.54
108.34	106	108.34
108.80	22	108.80
108.88	660	108.88
108.72	1	108.72
108.60	14	108.60
108.35	1,800	108.35
108.59	13	108.59
108.58	510	108.58
108.89	659	108.89
108.52	1,120	108.52
108.57	78	108.57
108.42	2	108.42
108.33	2,459	108.33
108.79	578	108.79
108.87	59	108.87
108.27	100	108.27
108.28	400	108.28
108.30	700	108.30
108.31	1,048	108.31
108.48	2	108.48
108.70	200	108.70
108.84	262	108.84
108.85	58	108.85
108.86	2	108.86
108.61	10	108.61
108.72	10	108.72
108.78	231	108.78
108.82	139	108.82
108.66	2,051	108.66
108.89	2	108.89
108.53	1	108.53
108.76	170	108.76
108.33	482	108.33
108.47	10	108.47
108.71	2	108.71
108.36	30	108.36
108.37	30	108.37
108.40	79	108.40
108.67	100	108.67

b. Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (USD) (Note 5)

c. Options transactions in respect of existing relevant securities

1. Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price (USD)	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)
Put Option	Selling	400	90.00	American	5/19/2023
Put Option	Selling	1,200	80.00	American	5/19/2023
Put Option	Selling	100	80.00	American	1/17/2025
Put Option	Selling	100	90.00	American	1/19/2024
Put Option	Selling	1,600	105.00	American	6/16/2023
Put Option	Selling	3,900	105.00	American	7/21/2023
Put Option	Selling	2,700	105.00	American	4/21/2023

ii. Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

1. Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None.

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure	5^th April 2023
Contact name	Roisin Nagle
Telephone number	[phone]
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap32

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1, RULE 8.3, RULE 38.5(b) AND

RULE 38.6 OF THE IRISH TAKEOVER PANEL ACT, 1997,

TAKEOVER RULES, 2022

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING

OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL AND

RIGHTS TO SUBSCRIBE FOR NEW SECURITIES

1. KEY INFORMATION

Full name of person making disclosure:	Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:	Horizon Therapeutics plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security	Product description e.g. call option	Written or purchased	Number of securities to which option or derivative relates	Exercise price per unit (USD)	Type e.g. American, European etc.	Expiry date
IE00BQPVQZ61	Put Option	Purchased	1,100	90.00	American	5/19/2023
IE00BQPVQZ61	Call Option	Purchased	11,500	110.00	American	5/19/2023
IE00BQPVQZ61	Call Option	Written	262,300	115.00	American	5/19/2023
IE00BQPVQZ61	Call Option	Purchased	42,500	120.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	5,200	110.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	2,900	80.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	300	80.00	American	1/17/2025
IE00BQPVQZ61	Put Option	Purchased	300	90.00	American	1/19/2024
IE00BQPVQZ61	Call Option	Purchased	1,200	110.00	American	8/18/2023
IE00BQPVQZ61	Call Option	Written	1,200	115.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Written	50,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	29,000	80.00	American	8/18/2023
IE00BQPVQZ61	Put Option	Purchased	251,600	100.00	American	5/19/2023
IE00BQPVQZ61	Put Option	Purchased	3,600	105.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	10,900	105.00	American	7/21/2023
IE00BQPVQZ61	Put Option	Purchased	5,200	105.00	American	4/21/2023
IE00BQPVQZ61	Call Option	Written	100,000	115.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Written	100,000	85.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	155,000	100.00	American	6/16/2023
IE00BQPVQZ61	Call Option	Purchased	300	110.00	American	6/16/2023
IE00BQPVQZ61	Put Option	Purchased	300	110.00	American	6/16/2023

3. AGREEMENTS TO PURCHASE OR SELL

Full details should be given so that the nature of the interest or position can be fully understood:

Ap33

4. RIGHTS TO SUBSCRIBE FOR NEW SECURITIES (INCLUDING DIRECTORS’ AND OTHER EMPLOYEE OPTIONS)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

It is not necessary to provide details on a Supplemental Form with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

References in these notes to “the Rules” are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

Category Code: RET

Sequence Number: 1079321

Time of Receipt (offset from UTC): 20230405T124824+0100